pre-IPO PHARMA

COMPANY OVERVIEW

Changing lives through the REstoration of neural NETworks. RenetX Bio's mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.


LOCATION

  • New Haven, CT, USA

  • THERAPEUTIC AREAS

  • Neurological Disorders
  • Ophthalmology

  • WEBSITE

    https://www.renetx.com/


    CAREER WEBSITE

    https://www.renetx.com/career-opportunities.html


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Aug 14, 2019

    ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204


    Jun 19, 2019

    ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury


    For More Press Releases


    Google Analytics Alternative